A new study led by investigators of a Harvard-affiliated teaching hospital found that Novo Nordisk's (NVO) GLP-1 drugs Ozempic and Wegovy could be linked to rare cases of vision loss.
Key Insights Amgen's estimated fair value is US$537 based on 2 Stage Free Cash Flow to Equity Amgen's US$309 share...
The Dow Jones Industrial Average and the other major stock indexes remained lower Tuesday as investors digested comments from Federal Reserve Chairman Jerome Powell. Bucking the tide was electric-vehicle giant Tesla[ticker symb=TSLA], which surged after beating delivery forecasts on the stock market today.